A Promising Small Molecule for Vanishing White Matter Disease
By: Divakar S Mithal and Jennifer P Rubin
References
- Sidrauski C Tsai JC Kampmann M Hearn BR Vedantham P Jaishankar P Pharmacological dimerization and activation of the exchange factor eIF2B antagonizes the integrated stress response eLife 2015 Apr 4 e07314 https://doi.org/10.7554/eLife.07314 25875391
- Wong YL LeBon L Edalji R Lim HB Sun C Sidrauski C The small molecule ISRIB rescues the stability and activity of Vanishing White Matter Disease eIF2B mutant complexes eLife 2018 Feb 7 e32733 https://doi.org/10.7554/eLife.32733 29489452
- van der Knaap MS Barth PG Gabreëls FJ Franzoni E Begeer JH Stroink H A new leukoencephalopathy with vanishing white matter Neurology 1997 Apr 48 4 845 55 https://doi.org/10.1212/WNL.48.4.845 9109866
- Gomez E Mohammad SS Pavitt GD Characterization of the minimal catalytic domain within eIF2B: the guanine-nucleotide exchange factor for translation initiation EMBO J 2002 Oct 21 19 5292 301 https://doi.org/10.1093/emboj/cdf515 12356745
DOI: https://doi.org/10.15844/pedneurbriefs-32-5 | Journal eISSN: 2166-6482
Language: English
Page range: 5 - 5
Submitted on: May 25, 2018
Accepted on: Jun 5, 2018
Published on: Aug 28, 2018
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
Keywords:
© 2018 Divakar S Mithal, Jennifer P Rubin, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.